“Integrated Safety Analysis of Abrocitinib in 3850 Patients With Moderate-To-Severe Atopic Dermatitis: Data From More Than 9600 Patient-Years With Up to 6.5 Years of Exposure”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s616. Accessed April 19, 2026. https://skin.dermsquared.com/skin/article/view/3820.